Physicochemical Properties
Molecular Formula | C9H8O3 |
Molecular Weight | 164.16 |
Exact Mass | 164.047 |
CAS # | 614-60-8 |
PubChem CID | 637540 |
Appearance | White to off-white solid powder |
Density | 1.3±0.1 g/cm3 |
Boiling Point | 348.0±17.0 °C at 760 mmHg |
Melting Point | 217ºC |
Flash Point | 178.5±17.4 °C |
Vapour Pressure | 0.0±0.8 mmHg at 25°C |
Index of Refraction | 1.660 |
LogP | 2.43 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Heavy Atom Count | 12 |
Complexity | 186 |
Defined Atom Stereocenter Count | 0 |
SMILES | C1=CC=C(C(=C1)/C=C/C(=O)O)O |
InChi Key | PMOWTIHVNWZYFI-AATRIKPKSA-N |
InChi Code | InChI=1S/C9H8O3/c10-8-4-2-1-3-7(8)5-6-9(11)12/h1-6,10H,(H,11,12)/b6-5+ |
Chemical Name | (E)-3-(2-hydroxyphenyl)prop-2-enoic acid |
HS Tariff Code | 2934.99.9001 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
Targets | HIV Human Endogenous Metabolite |
References |
[1]. A new coumarin and cytotoxic activities of constituents from Cinnamomum cassia. Nat Prod Commun. 2014 Apr;9(4):487-8. [2]. Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection. Antiviral Res. 2009 Apr;82(1):73-81. |
Additional Infomation |
2-coumaric acid is a monohydroxycinnamic acid in which the hydroxy substituent is located at C-2 of the phenyl ring. It has a role as a plant metabolite. It is a conjugate acid of a 2-coumarate. 2-Hydroxycinnamic acid has been reported in Rhododendron dauricum, Humulus lupulus, and other organisms with data available. See also: Ipomoea aquatica leaf (part of). |
Solubility Data
Solubility (In Vitro) | DMSO : 100 mg/mL (609.16 mM) |
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (15.23 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (15.23 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (15.23 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 6.0916 mL | 30.4581 mL | 60.9162 mL | |
5 mM | 1.2183 mL | 6.0916 mL | 12.1832 mL | |
10 mM | 0.6092 mL | 3.0458 mL | 6.0916 mL |